Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore

: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐deriv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 1999-05, Vol.72 (5), p.1802-1811
Hauptverfasser: Schipper, H. M., Bernier, L., Mehindate, K., Frankel, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1811
container_issue 5
container_start_page 1802
container_title Journal of neurochemistry
container_volume 72
creator Schipper, H. M.
Bernier, L.
Mehindate, K.
Frankel, D.
description : Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.
doi_str_mv 10.1046/j.1471-4159.1999.0721802.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17300336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17300336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</originalsourceid><addsrcrecordid>eNqVkctuEzEUhi0EoqHwCshCiN0Mx557N6gKlxa1tIKytjye48SRZxzsiUh2LHiAPmOfBE8TAdtufNH_nePj_yfkFYOUQV6-XaUsr1iSs6JJWdM0KVSc1cDT7SMy-ys9JjMAzpMMcn5EnoWwAmBlXrKn5IgBZxUvyhn5fWlGp5Zu6LyRlp57N9Bv-GODYfRyNPFmBvrerWVvBrz7dTtfSmtxWGBHTyPiFtbIE_rVWaRO0zPskV5tdwscZJhwRuXQ0XGJ9Bp9j7I11ow7euPlEMx9-2vn8Tl5oqUN-OKwH5PvHz_czM-Si6tP5_PTi0TldcaTQmOh27ZhWFYd1zVXBei45MB11dZdlHletxpUxRSoDJqOFzlqHoWmqLvsmLzZ9117d_9F0Zug0Fo5oNsEwaoMIMvKCJ7sQeVdCB61WHvTS78TDMSUgViJyWgxGS2mDMQhA7GNxS8Pr2zaHrv_SvemR-D1AZBBSaujGcqEf1wNcdwmYu_22E9jcfeACcTnL_PplP0BS7imkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17300336</pqid></control><display><type>article</type><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><source>MEDLINE</source><source>Wiley Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</creator><creatorcontrib>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</creatorcontrib><description>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1046/j.1471-4159.1999.0721802.x</identifier><identifier>PMID: 10217256</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Astrocyte ; Astrocytes - drug effects ; Astrocytes - metabolism ; Biological and medical sciences ; Cells, Cultured ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dopamine - pharmacology ; Dopamine Agents - pharmacology ; Heme Oxygenase (Decyclizing) - physiology ; Heme Oxygenase-1 ; Hydrogen Peroxide - pharmacology ; Intracellular Membranes - metabolism ; Iron ; Iron - metabolism ; Levodopa - pharmacology ; Medical sciences ; Mitochondria ; Mitochondria - metabolism ; Neurology ; Norepinephrine - pharmacology ; Oxidants - pharmacology ; Oxidative stress ; Parkinson's disease ; Permeability ; Permeability transition pore ; Rats ; Rats, Sprague-Dawley ; Vitamin K - pharmacology</subject><ispartof>Journal of neurochemistry, 1999-05, Vol.72 (5), p.1802-1811</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</citedby><cites>FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1471-4159.1999.0721802.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1471-4159.1999.0721802.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1805959$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10217256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schipper, H. M.</creatorcontrib><creatorcontrib>Bernier, L.</creatorcontrib><creatorcontrib>Mehindate, K.</creatorcontrib><creatorcontrib>Frankel, D.</creatorcontrib><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</description><subject>Animals</subject><subject>Astrocyte</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Agents - pharmacology</subject><subject>Heme Oxygenase (Decyclizing) - physiology</subject><subject>Heme Oxygenase-1</subject><subject>Hydrogen Peroxide - pharmacology</subject><subject>Intracellular Membranes - metabolism</subject><subject>Iron</subject><subject>Iron - metabolism</subject><subject>Levodopa - pharmacology</subject><subject>Medical sciences</subject><subject>Mitochondria</subject><subject>Mitochondria - metabolism</subject><subject>Neurology</subject><subject>Norepinephrine - pharmacology</subject><subject>Oxidants - pharmacology</subject><subject>Oxidative stress</subject><subject>Parkinson's disease</subject><subject>Permeability</subject><subject>Permeability transition pore</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Vitamin K - pharmacology</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkctuEzEUhi0EoqHwCshCiN0Mx557N6gKlxa1tIKytjye48SRZxzsiUh2LHiAPmOfBE8TAdtufNH_nePj_yfkFYOUQV6-XaUsr1iSs6JJWdM0KVSc1cDT7SMy-ys9JjMAzpMMcn5EnoWwAmBlXrKn5IgBZxUvyhn5fWlGp5Zu6LyRlp57N9Bv-GODYfRyNPFmBvrerWVvBrz7dTtfSmtxWGBHTyPiFtbIE_rVWaRO0zPskV5tdwscZJhwRuXQ0XGJ9Bp9j7I11ow7euPlEMx9-2vn8Tl5oqUN-OKwH5PvHz_czM-Si6tP5_PTi0TldcaTQmOh27ZhWFYd1zVXBei45MB11dZdlHletxpUxRSoDJqOFzlqHoWmqLvsmLzZ9117d_9F0Zug0Fo5oNsEwaoMIMvKCJ7sQeVdCB61WHvTS78TDMSUgViJyWgxGS2mDMQhA7GNxS8Pr2zaHrv_SvemR-D1AZBBSaujGcqEf1wNcdwmYu_22E9jcfeACcTnL_PplP0BS7imkA</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>Schipper, H. M.</creator><creator>Bernier, L.</creator><creator>Mehindate, K.</creator><creator>Frankel, D.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>199905</creationdate><title>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</title><author>Schipper, H. M. ; Bernier, L. ; Mehindate, K. ; Frankel, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4832-5fe5fbb91e67d2f82c50f2c5402f7b8dfe5248bf0c71c0c309d254ef2fe5958d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Astrocyte</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Agents - pharmacology</topic><topic>Heme Oxygenase (Decyclizing) - physiology</topic><topic>Heme Oxygenase-1</topic><topic>Hydrogen Peroxide - pharmacology</topic><topic>Intracellular Membranes - metabolism</topic><topic>Iron</topic><topic>Iron - metabolism</topic><topic>Levodopa - pharmacology</topic><topic>Medical sciences</topic><topic>Mitochondria</topic><topic>Mitochondria - metabolism</topic><topic>Neurology</topic><topic>Norepinephrine - pharmacology</topic><topic>Oxidants - pharmacology</topic><topic>Oxidative stress</topic><topic>Parkinson's disease</topic><topic>Permeability</topic><topic>Permeability transition pore</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Vitamin K - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schipper, H. M.</creatorcontrib><creatorcontrib>Bernier, L.</creatorcontrib><creatorcontrib>Mehindate, K.</creatorcontrib><creatorcontrib>Frankel, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schipper, H. M.</au><au>Bernier, L.</au><au>Mehindate, K.</au><au>Frankel, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>1999-05</date><risdate>1999</risdate><volume>72</volume><issue>5</issue><spage>1802</spage><epage>1811</epage><pages>1802-1811</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>: Little is currently known concerning the mechanisms responsible for the excessive deposition of redox‐active iron in the substantia nigra of subjects with Parkinson's disease (PD). In the present study, we demonstrate that dopamine promotes the selective sequestration of non‐transferrin‐derived iron by the mitochondrial compartment of cultured rat astroglia and that the mechanism underlying this novel dopamine effect is oxidative in nature. We also provide evidence that up‐regulation of the stress protein heme oxygenase‐1 (HO‐1) is both necessary and sufficient for mitochondrial iron trapping in dopamine‐challenged astroglia. Finally, we show that opening of the mitochondrial transition pore (MTP) mediates the influx of non‐transferrin‐derived iron into mitochondria of dopamine‐stimulated and HO‐1‐transfected astroglia. Our findings provide an explanation for the pathological iron sequestration, mitochondrial insufficiency, and amplification of oxidative injury reported in the brains of PD subjects. Pharmacological blockade of transition metal trapping by “stressed” astroglial mitochondria (e.g., using HO‐1 inhibitors or modulators of the MTP) may afford effective neuroprotection in patients with PD and other neurological afflictions.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10217256</pmid><doi>10.1046/j.1471-4159.1999.0721802.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 1999-05, Vol.72 (5), p.1802-1811
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_17300336
source MEDLINE; Wiley Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Free Full-Text Journals in Chemistry
subjects Animals
Astrocyte
Astrocytes - drug effects
Astrocytes - metabolism
Biological and medical sciences
Cells, Cultured
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dopamine - pharmacology
Dopamine Agents - pharmacology
Heme Oxygenase (Decyclizing) - physiology
Heme Oxygenase-1
Hydrogen Peroxide - pharmacology
Intracellular Membranes - metabolism
Iron
Iron - metabolism
Levodopa - pharmacology
Medical sciences
Mitochondria
Mitochondria - metabolism
Neurology
Norepinephrine - pharmacology
Oxidants - pharmacology
Oxidative stress
Parkinson's disease
Permeability
Permeability transition pore
Rats
Rats, Sprague-Dawley
Vitamin K - pharmacology
title Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A01%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20Iron%20Sequestration%20in%20Dopamine%E2%80%90Challenged%20Astroglia:%20Role%20of%20Heme%20Oxygenase%E2%80%901%20and%20the%20Permeability%20Transition%20Pore&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Schipper,%20H.%20M.&rft.date=1999-05&rft.volume=72&rft.issue=5&rft.spage=1802&rft.epage=1811&rft.pages=1802-1811&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1046/j.1471-4159.1999.0721802.x&rft_dat=%3Cproquest_cross%3E17300336%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17300336&rft_id=info:pmid/10217256&rfr_iscdi=true